Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury

ConclusionsIn patients discharged alive from the ICU after experiencing AKI, ACEi/ARB prescription at discharge is associated with a decrease in 1-year mortality.Trial registrationClinicalTrials.gov NCT01367093. Registered on 6 June 2011.

Source: Intensive Care Medicine - May 15, 2018 Category: Intensive Care Source Type: research